clinical trial

Photo courtesy of Janssen Pharmaceutical Companies. From left to right: panel moderator Patrick Wayte, Dr. C. Michael Gibson and Dr. Paul Stoffels.

By Dave Muoio 01:23 pm November 18, 2019
Due to the promises of lower costs, simple scaling and greater patient engagement, digital technologies are all but an inevitability for the drug trials of tomorrow, according to experts from pharma and the clinical research community speaking this weekend at the American Heart Association Scientific Sessions in Philadelphia. These comments were accompanied by the official kickoff of CHIEF-HF,...
By Dave Muoio 03:50 pm November 7, 2019
AiCure, a nearly decade-old startup using artificial intelligence to measure medication adherence and other behavior during clinical trials or normal care, has brought in $24.5 million in Series C funding. Palisades Growth Capital led the raise, which also featured new backers Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners, and SpringRock Ventures. The round also included all...
By Laura Lovett 11:12 am September 11, 2019
When it comes to clinical trials, oftentimes the majority of a patient’s experience happens “off stage” in their home or community. For example, medication adherence, or nonadherence, has been a major pitfall in medicine. Studies have found that roughly one in five new prescriptions are never filled, and of those filled up to 50% are taken incorrectly.  Startups have taken notice and the digital...
By Dave Muoio 10:47 am July 31, 2019
Litmus Health announced yesterday the release of a new version of its device-friendly clinical research platform for the collection and analysis of real-world data. Built with new features to help pharmaceutical companies from the beginning to the end of their drug trials, the platform now adds Actigraph’s medical-grade wearables to its repertoire of supported devices, which previously included...

Verisense by Shimmer IMU (Photo courtesy Shimmer)

By Jonah Comstock 01:35 pm February 19, 2019
Shimmer, a Dublin-based wearable sensor company, has launched a new sensor platform for clinical trials called VeriSense. At launch, the platform will work with Shimmer's IMU, or inertial measurement unit, sensor, which can measure activity and sleep from the wrist, as well as network with sensors elsewhere on the body to monitor musculoskeletal and neurological conditions. The company has been...
By Laura Lovett 01:03 pm October 9, 2018
Biopharmaceutical service Parexel International Corporation is turning its attention to mobile and wearable technology to aid drug development and clinical research. This morning the Boston-based company announced a slew of new products that will be built on its Perceptive Cloud platform.  One of the new technologies uses Microsoft’s Azure App Services and will be able to send patient data to...
By Jonah Comstock 04:30 pm May 16, 2018
Cambridge, Massachusetts-based sensor maker MC10, known for its flexible and stretchable electronics, has received its first FDA 510(k) clearance for the BioStamp nPoint system. BioStamp nPoint is a more advanced version of the company's non-FDA cleared BioStampRC. "BiostampRC was primarily developed as an investigational tool, primarily used by academia, as well as by pharmaceutical companies,...
By Laura Lovett 12:23 pm March 8, 2018
The Mayo Clinic has just released the results of a new study, which show an 80 percent increase in enrollment of clinical trials for breast cancer when using IBM’s Watson for Clinical Trial matching system.  The Watson system uses artificial intelligence to analyze unstructured information and pull out insights from the data.  “Watson is able to give us faster, better matching of patients to...
By Heather Mack 02:58 pm January 11, 2017
Cambridge, Massachusetts-based Clinical Research IO, which developed an electronic platform for researchers to quickly capture data during clinical trials, has raised $1.6 million in seed funding in a round led by NXT Ventures and Rally Ventures. Previously, the company raised $800,000, and the latest funding brings the company’s total to $2.4 million. The funding will be used to develop Clinical...
By Jonah Comstock 02:04 pm May 10, 2016
New York City-based ProofPilot, a startup creating technology to help anyone launch a randomized control trial, has re-launched its clinical trial product. The software-as-a-service product is available to academic and clinical researchers as well as individuals, non-profits, and community groups. There are a range of versions at different price points, with the lowest being free and the highest...